News

3. Dec 2024

News Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001

3. Dec 2024

News Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate for Select Solid Tumor Target

8. Oct 2024

News Building Radar raises $7.2M to deploy AI into construction sales software

11. Sep 2024

News Qualifyze swallows $54M to improve pharmaceutical supply chains

16. Jul 2024

News CatalYm Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab

9. Apr 2024

News FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer

12. Mar 2024

News "Coffee with coparion. Brewing Tech Insights” – coparion's new podcast series.

14. Sep 2023

News Jens Rassloff Appointed as Chair of the Advisory Board